Intrinsic Value of S&P & Nasdaq Contact Us

Fennec Pharmaceuticals Inc. FENC

NASDAQ Capital Marke

SharesGrow Score
54/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$18.00
+188%

Fennec Pharmaceuticals Inc. (FENC) current share price is $6.25. The gold spot price is $4,808.10 per troy ounce. Using the formula: FENC in gold = $6.25 × 31.1035 ÷ $4,808.10 = 0.0404 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of FENC when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding FENC shares over the measured period.

FENC in US Dollars
Gold in US Dollars
FENC in Gold (grams per share)

Real Wealth Growth Rate

FENC
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{FENC}_{\text{gold}}(t) = \frac{P_{\text{FENC}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{FENC}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{FENC}_{\text{gold}}^{(T)}}{\text{FENC}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{FENC}_\text{gold}^{(0)}$ = initial gold-price, $\text{FENC}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

EWTX
EWTX
Edgewise Therapeutics, Inc.
$33.16
-2.01%
IRON
IRON
Disc Medicine, Inc.
$70.48
+2.95%
HRMY
HRMY
Harmony Biosciences Holdings, Inc.
$29.29
+0.83%
OLMA
OLMA
Olema Pharmaceuticals, Inc.
$16.30
+2.32%
JANX
JANX
Janux Therapeutics, Inc.
$15.24
+2.28%
IKNA
IKNA
Ikena Oncology, Inc.
$17.16
+1,152.55%
KROS
KROS
Keros Therapeutics, Inc.
$11.55
+3.59%
LRMR
LRMR
Larimar Therapeutics, Inc.
$4.87
+0.21%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message